Skip to main content

Table 1 Diameter of the lesions before and after NAC by CESM and after NAC by histopathology

From: Role of contrast-enhanced spectral mammography in the assessment of residual disease following neoadjuvant chemotherapy in patients with breast cancer

 

Minimal diameter

Maximal diameter

Mean ± SD

CESM pre-NAC (cm)

1.3

15.0

6.0 ± 3.6

CESM post-NAC (cm)

0.0

11.0

3.63 ± 3.1

Histopathology post-NAC (cm)

0.0

11.0

3.7 ± 2.9

  1. CESM contrast-enhanced spectral mammography, NAC neoadjuvant chemotherapy, SD standard deviation